Päivi Halonen

897 total citations
29 papers, 360 citations indexed

About

Päivi Halonen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Päivi Halonen has authored 29 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Päivi Halonen's work include Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Päivi Halonen is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Päivi Halonen collaborates with scholars based in Finland, Sweden and Denmark. Päivi Halonen's co-authors include Anne Mäkipernaa, Matti K. Salo, Z. I. Ali, Tarja Ruuska, Clare J. Fowler, Jorma Mattila, Pauli Suominen, H. Lang, J.-P. Halonen and Hannu Kalimo and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Cancer Research.

In The Last Decade

Päivi Halonen

24 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Päivi Halonen Finland 11 75 57 56 53 50 29 360
Paul G. Mathew United States 15 36 0.5× 24 0.4× 111 2.0× 48 0.9× 43 0.9× 46 572
G. Mollìca Italy 12 38 0.5× 67 1.2× 48 0.9× 36 0.7× 31 0.6× 37 619
Alev Güven Türkiye 12 82 1.1× 30 0.5× 51 0.9× 20 0.4× 27 0.5× 31 408
Gideon Findler Israel 16 48 0.6× 95 1.7× 43 0.8× 36 0.7× 40 0.8× 30 492
Cecilio Poyatos Spain 11 50 0.7× 16 0.3× 91 1.6× 38 0.7× 34 0.7× 17 411
A. Karagiannis Greece 12 34 0.5× 26 0.5× 16 0.3× 13 0.2× 10 0.2× 24 450
Tyler Scullen United States 13 20 0.3× 44 0.8× 15 0.3× 26 0.5× 48 1.0× 68 538
Aydan Değerli̇yurt Türkiye 12 52 0.7× 29 0.5× 50 0.9× 16 0.3× 22 0.4× 36 391
Temel Tombul Türkiye 13 28 0.4× 26 0.5× 26 0.5× 8 0.2× 12 0.2× 47 448
Gülay Nurlu Türkiye 12 12 0.2× 26 0.5× 22 0.4× 22 0.4× 24 0.5× 31 432

Countries citing papers authored by Päivi Halonen

Since Specialization
Citations

This map shows the geographic impact of Päivi Halonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Päivi Halonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Päivi Halonen more than expected).

Fields of papers citing papers by Päivi Halonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Päivi Halonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Päivi Halonen. The network helps show where Päivi Halonen may publish in the future.

Co-authorship network of co-authors of Päivi Halonen

This figure shows the co-authorship network connecting the top 25 collaborators of Päivi Halonen. A scholar is included among the top collaborators of Päivi Halonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Päivi Halonen. Päivi Halonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Österlund, Pia, Timo Muhonen, Emerik Österlund, et al.. (2025). Relapse patterns, risk factors, re-resectability and survival after curative treatment for metastatic colorectal cancer (mCRC): A RAXO substudy.. Journal of Clinical Oncology. 43(16_suppl). 3566–3566.
2.
Joensuu, Heikki, Judith Fraser, Hans Wildiers, et al.. (2024). Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer. JAMA Network Open. 7(8). e2429772–e2429772.
3.
4.
Heervä, Eetu, Ari Ristimäki, Soili Kytölä, et al.. (2023). PD-19 Finnish population-based metastatic colorectal cancer data collection study – comparison with the prospective RAXO study. Annals of Oncology. 34. S8–S9.
5.
6.
7.
Österlund, Pia, Päivi Halonen, Leena‐Maija Soveri, et al.. (2020). Feasibility of switching to S-1 after other fluoropyrimidine-related cardiotoxicity during chemotherapy for solid tumors.. Journal of Clinical Oncology. 38(15_suppl). 7037–7037. 2 indexed citations
8.
Österlund, Pia, Tapio Salminen, Annika Ålgars, et al.. (2019). Patient characteristics associated with poor performance status, ECOG 2-3, and effect on survival in 1086 Finnish metastatic colorectal cancers (mCRC) nationwide (prospective RAXO study). Annals of Oncology. 30. v245–v245. 1 indexed citations
9.
Tenhunen, Mikko, et al.. (2013). First-day iodine kinetics is useful for individualizing radiation safety precautions for thyroid carcinoma patients. Nuclear Medicine Communications. 34(12). 1208–1215. 3 indexed citations
10.
Ruutiainen, Juhani, et al.. (2009). Treatment of acute exacerbations in early multiple sclerosis: cyclosporin A or prednisolone?. Acta Neurologica Scandinavica. 83(1). 52–54. 1 indexed citations
11.
Halonen, Päivi, et al.. (2009). Quantitative vibration perception thresholds in patients under prolonged antiepileptic treatment. Acta Neurologica Scandinavica. 72(3). 307–311.
12.
Halonen, Päivi, Jorma Mattila, Anne Mäkipernaa, Tarja Ruuska, & Kjeld Schmiegelow. (2006). Erythrocyte concentrations of metabolites or cumulative doses of 6‐mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia. Pediatric Blood & Cancer. 46(7). 762–766. 10 indexed citations
13.
Halonen, Päivi, A. Alanen, Hannu Kalimo, et al.. (2006). Facioscapulohumeral Muscular Dystrophy. Humana Press eBooks. 106(17). 375–379. 1 indexed citations
14.
Halonen, Päivi, Jorma Mattila, Tarja Ruuska, Matti K. Salo, & Anne Mäkipernaa. (2003). Liver histology after current intensified therapy for childhood acute lymphoblastic leukemia: microvesicular fatty change and siderosis are the main findings. Medical and Pediatric Oncology. 40(3). 148–154. 21 indexed citations
15.
Halonen, Päivi, Matti K. Salo, Kjeld Schmiegelow, & Anne Mäkipernaa. (2003). Investigation of the mechanisms of therapy‐related hypoglycaemia in children with acute lymphoblastic leukaemia. Acta Paediatrica. 92(1). 37–42. 13 indexed citations
16.
Halonen, Päivi, Matti K. Salo, & Anne Mäkipernaa. (2001). Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia. The Journal of Pediatrics. 138(3). 428–431. 29 indexed citations
17.
Rinne, Juha O., et al.. (1994). Lyme borreliosis associated with complete flaccid paraplegia. Journal of Infection. 28(2). 181–184. 4 indexed citations
18.
Laurikainen, E., Kalle Aitasalo, Päivi Halonen, Johan A. K. Suykens, & Hannu Kalimo. (1992). Muscle pathology in idiopathic cricopharyngeal dysphagia. European Archives of Oto-Rhino-Laryngology. 249(4). 216–23. 14 indexed citations
19.
Kallajoki, Markku, et al.. (1991). Inclusion body myositis and paramyxoviruses. Human Pathology. 22(1). 29–32. 15 indexed citations
20.
Halonen, Päivi, et al.. (1986). Vibratory perception thresholds in shipyard workers exposed to solvents. Acta Neurologica Scandinavica. 73(6). 561–565. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul G. Mathew Breakdown of academic impact, for papers by G. Mollìca Breakdown of academic impact, for papers by Alev Güven Breakdown of academic impact, for papers by Gideon Findler Breakdown of academic impact, for papers by Cecilio Poyatos Breakdown of academic impact, for papers by A. Karagiannis Breakdown of academic impact, for papers by Tyler Scullen Breakdown of academic impact, for papers by Aydan Değerli̇yurt Breakdown of academic impact, for papers by Temel Tombul Breakdown of academic impact, for papers by Gülay Nurlu
Rankless by CCL
2026